[ACP] Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1

 关闭 求助已关闭
xiaoxiao1994 发表于 2026-7-28 17:26:38 | 显示全部楼层 |阅读模式
悬赏10积分

期刊:Annals of Internal Medicine

文献作者:Amy E. Colson; Gordon E. Crofoot; Peter J. Ruane; Moti N. Ramgopal; Alexandra W. Dretler; Ronald G. Nahass; Gary I. Sinclair; Mezgebe Berhe; Afsoon Roberts; Shauna Applin; Cynthia Brinson; Dushyantha Jayaweera; Kimberly A. Workowski; Fadi Shihadeh; Shan-Yu Liu; Stephanie Klopfer; Cyril Llamoso; Sharline Madera; Hadas Dvory-Sobol; Martin S. Rhee; Elizabeth G. Rhee; Jared M. Baeten; Joseph J. Eron

出版日期:2026-2-

DOI号:10.7326/annals-25-01939

下载链接:https://www.acpjournals.org/doi/pdf/10.7326/ANNALS-25-01939

文献链接:https://doi.org/10.7326/annals-25-01939

当前文献来源于 American College of Physicians


备注信息:
全部回复0 显示全部楼层

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

返回列表